Evidence map›Paper›PMID 19073729›Full record

ArticleJournal of virology2009

Herpes simplex virus type 1 thymidine kinase sequence fused to the lacz gene increases levels of {beta}-galactosidase activity per genome of high-capacity but not first-generation adenoviral vectors in vitro and in vivo.

M Puntel, R J Barrett, S Mondkar, V Saxena, K M Kroeger, A K M Muhammad, C Liu, N Bondale, S Sciascia, W Xiong and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

M PuntelGene Therapeutics Research Institute, Cedars-Sinai Medical Center, Department of Medicine, University of California Los Angeles, 90048, USA.
R J Barrett
S Mondkar
V Saxena
K M Kroeger
A K M Muhammad
C Liu
N Bondale
S Sciascia
W Xiong
Y Shi
A Salem
A Zadmehr
P Huynh
D Palmer
P Ng
M G Castro
P R Lowenstein
Cedars-Sinai Medical Center · USUniversity of California, Los Angeles · USBaylor College of Medicine · US

Funding

Improving Safety and Efficacy of Gene Therapy with HDAdR01DK067324 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI NG, PHILIP · 2005 to 2013
$3.5M
Gutless Adenovirus Mediated Gene Therapy for GliomaU01NS052465 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASTRO, MARIA G · 2007 to 2011
$3.1M
Gene therapy for chronic neurodegenerative disordersR01NS044556 · NINDS · CEDARS-SINAI MEDICAL CENTER · PI CASTRO, MARIA G · 2002 to 2006
$2.0M
Gene Therapy for Neurological DiseasesR01NS042893 · NINDS · CEDARS-SINAI MEDICAL CENTER · PI LOWENSTEIN, PEDRO R · 2002 to 2006
$1.8M
Gene Therapy and the Brain: Neuroimmune InteractionsR01NS054193 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LOWENSTEIN, PEDRO R. · 2007 to 2011
$1.6M
Gene Therapy for GliomaR21NS047298 · NINDS · CEDARS-SINAI MEDICAL CENTER · PI LOWENSTEIN, PEDRO R · 2003 to 2004
$354k
NIDDK NIH HHS R01 DK067324NIDDK NIH HHS R01DK067324NINDS NIH HHS 1R01 NS44556.01NINDS NIH HHS 1R21 NS047298-01NINDS NIH HHS 1 RO1 NS 054193.01NINDS NIH HHS 1UO1 NS052465.01NINDS NIH HHS NS445561NINDS NIH HHS R01 NS042893NINDS NIH HHS R01 NS044556NINDS NIH HHS R01 NS054193NINDS NIH HHS R01 NS 42893.01NINDS NIH HHS R21 NS047298NINDS NIH HHS U01 NS052465PHS HHS 1R21-NSO54143.01
6 · The paper itself

Abstract

Increased transgene expression per vector genome is an important goal in the optimization of viral vectors for gene therapy. Herein we demonstrate that herpes simplex virus type 1 (HSV1) thymidine kinase (TK) gene sequences (1,131 bp) fused to the 3' end of lacZ increase transgene expression from high-capacity adenoviral vectors (HCAd), but not from first-generation (Ad) vectors. The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), in contrast, increased transgene expression levels from Ad but not HCAd vectors. The differential activity of the HSV1 TK gene and WPRE sequences was detected both in vitro and in vivo and suggests potentially different mechanisms of action or the interaction of these elements with vector genomic sequences.

Indexed as

Genetic VectorsAdenoviridaebeta-GalactosidaseGene ExpressionHepatitis B Virus, WoodchuckHerpesvirus 1, HumanRecombinant Fusion ProteinsThymidine Kinasebeta-GalactosidaseRecombinant Fusion ProteinsThymidine Kinase

Identifiers

PMID19073729
PMCPMC2643782
OpenAlexW1999063315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.